Filter by type Show all Pages Solutions Expertise Reports News Webinars Events Locations FAQs Case Studies Whitepapers Filter By Any Pages Solutions Expertise Reports News Webinars Events Locations FAQs Case Studies Whitepapers Expertise Oncology CRO services The landscape of Oncology in Asia-Pacific Biotechnology companies are facing increased challenges around participant recruitment and rete October 16, 2017 News The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in… The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in A Read more May 26, 2023 News Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development… Chicago, IL USA - Novotech, the leading Asia Pacific centred biotech CRO is spon Read more July 15, 2020 Webinar Advancing oncology trials in Asia-Pacific Arsalan Arif: Watch August 27, 2019 Case Study Biotechnology company looking for Oncology CRO services. Regulatory and recruitment expertise… The Background When South Korean oncology biotechnology company PharmAbcine completed a successful domestic phase I study for Read More June 6, 2022 News Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in… Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has rec Read more June 2, 2022 News Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and… Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded it Read more May 30, 2022 Webinar Development and Regulatory Strategy for US and China Speakers and Panelists Bio： Watch December 21, 2022 News Novotech Sponsors “The Next Big Thing in Cancer Care” Webinar - CAR-T, Precision Oncology, AI and… Novotech, the Asia Pacific centered biotech specialist CRO, presents “The Next Big Thing in Cance Read more April 13, 2023 News Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer… Novotech, the leading Asia Pacific centred biotech CRO joins oncology leaders at the eChinaHealth Read more June 14, 2023 Webinar Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from… Arsalan Arif: Hi, everyone. Arsalan Arif here with Endpoints News. Watch September 5, 2022 News Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC Meet the team at Booth #409 Read more October 7, 2022 News Featured in the endpoints news- the factors driving a rapid evolution of gene & cell therapy and… APAC is the fast growing region globally for cell & gene therapy trials representing Read more June 7, 2022 Webinar Accelerating clinical development in China & the US With experienced clinical teams in both regions, Novotech will share real-world success strategies for biot Watch May 22, 2020 News New research shows high continuity at clinical sites in Asia-Pacific for oncology studies New research conducted by the Cancer Research Institute suggested oncology clinical research site Read more November 15, 2019 News Asia-Pacific shows higher patient recruitment rates for Oncology clinical trials Biotechnology companies are facing tremendous challenges around Read more August 25, 2019 Case Study Rescue study and Oncology CRO services. Local know-how gets pivotal breast cancer trial back on… The Background When recruitment for a global breast cancer trial was lagging, Novotech was engaged as the Asia Pacific regional Read More November 20, 2019 News Novotech discusses biotechnology CRO services at leadership meeting in Malaysia Novotech is a full service CRO, offering CRO services across all the Asia-Pacific region with ope Read more May 30, 2022 Webinar Go/No Go Decisions Based on Early Phase Oncology Trials Panel Discussion Dr. Jin Li, Shanghai East Hospital Dr. Watch March 14, 2023 News Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published Read more September 29, 2017 News Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project Almost half of these occur in Asia with almost one quarter of the global burden in China. Read more January 23, 2023 Webinar The Next Big Thing in Cancer Care Dr. Peter Paul Yu: Watch September 5, 2023 Whitepaper Rare Disease – Global Clinical Trial Landscape (2018-2022) Exploring the Rare Diseases Global Clinical Trials Landscape: Unveiling Challenges, Trends, and Promising Adv Download September 2, 2022 News APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a repor Read more September 13, 2023 FAQ Rare Disease Clinical Trials: Unveiling Insights and Charting Progress A rare disease, as defined by the WHO, is one that affects fewer than one person in every 1,000 and is typically deadly. Read More October 5, 2017 News Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO The announcement was made at the ASCO Annual Meeting (May 31 - June 4, 2019 McCormick Place, Chi Read more January 6, 2020 News Immuno-Oncology clinical trial landscape in Asia-Pacific A growing number of biotechnology companies are looking at Asia and Australia to run their Read more February 11, 2021 News Celebrating International Day for Women and Girls in Science 2021 Thursday 11 February 2021 Read more April 3, 2023 FAQ The Cell & Gene Therapy Clinical Trials Global Landscape Cell & gene therapies have emerged as revolutionary treatments for a variety of diseases, including cancer, genetic disorders, and autoimmune conditions. Read More Greater China At more than 1.4 billion people, China is the world’s most populated country, with an increasing February 2, 2023 News Asia Pacific Cell & Gene Research Growing 50% Faster than ROW Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Read more March 24, 2021 Webinar Asia Pacific: The solution for accelerating your clinical trial program Ms Norial: Hi everyone and thank you for joining our Novotech presentation on Asia Pacific Watch March 3, 2023 News Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trial Read more February 10, 2023 News Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phas Read more April 1, 2022 FAQ Clinical Trends of 2022 2022 marks the third year of the worldwide COVID-19 pandemic, which continues to fuel the transformation of the clinical trial and the research industry. Read More September 25, 2020 Webinar Accelerating Clinical Trials in Australia and Asia – Presented by Steven Roan at OCT USA Hello, good morning, good afternoon, good evening. Thank you very much for taking the time to join the pre Watch December 17, 2021 Report Pancreatic cancer Clinical trials landscape Asia pacific The incidence of pancreatic cancer is rising in Asia-Pacific, with the region accounting for about half of new cases in 2020. Download April 6, 2023 Report Breast Cancer- Global Clinical Trial Landscape- Focus on Asia Pacific Asia accounted for approximately 45% of the global breast cancer cases in 2020, with Mainland China, India, and Japan contributing the majority of cases. Download May 26, 2022 Whitepaper Next Generation Sequencing NGS profiling improves patient outcomes while also lowering treatment costs and time to diagnosis for cancer patients Download June 26, 2023 Report Liver Cancer Global Clinical trial landscape- Focus on Asia Pacific Asia accounted for more than 70% of worldwide liver cancer incidence cases in 2020, with China contributing the majority. Download November 29, 2021 Report Lung cancer (nsclc) clinical trials landscape asia pacific In Asia, lung cancer ranks as the most prevalent cancer and the primary cause of mortality, with the region accounting for almost 60% of the global incidence of lung cancer. Download March 2, 2023 Whitepaper Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific Asia Pacific has been the fastest growing region in multi-specific monoclonal antibody trials since 2018, with the re Download March 31, 2022 Report Triple negative breast Cancer With a high population density and over 45% of the global breast cancer incidence, Asia is expected to account for more than half of all TNBC cases, with a large TNBC patient pool, particularly in Download May 26, 2023 Report Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific Asia accounted for more than 40% of the world's Non-Hodgkin Lymphoma incidence in 2020, with China contributing the majority. Download November 3, 2021 Report Esophageal cancer – Clinical trials landscape – Asia pacific In Asia, EC is the sixth most common cancer, with the region constituting almost 80% of the new EC cases globally. The highest standardized incidence rate has been observed in East Asia. Download November 22, 2022 News Oncoshot and Novotech Partner to Offer Cancer Data Insights SINGAPORE, October 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research Read more January 21, 2022 Report Bladder cancer Asia accounted for over a third of the global bladder cancer incidence with over 200,00 newly diagnosed cases, with China having a higher prevalence of bladder cancer in 2020. Download May 2, 2023 Whitepaper RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific Asia Pacific had the fastest five-year growth rate compared to rest of the world in RNA therapy trials with the regio Download September 17, 2021 Report Clinical trial landscape of endometrial cancer in asia-pacific In 2020, Globocan reported over 400,000 new corpus uteri cases, with Asia accounting for about 40% of these new cases. Download August 5, 2022 Whitepaper Immuno-oncology – Asia pacific – clinical Trial landscape Asia Pacific has shown significant increase in Immuno-oncology trials between 2017 and 2021 and contributes to more than a third of the global clinical development of Immune-oncology drugs. Download February 15, 2021 Report AML Landscape in Asia-Pacific AML is the most common form of leukemia in adults, accounting for approximately a third of all leukemia cases worldwide. Download December 17, 2021 Report Cervical cancer Asia pacific Clinical trial landscape Asia accounts for almost 60% of the global incidence of cervical cancer, with India and China together contributing to more than a third of all cases and deaths. Download April 27, 2023 Report Melanoma - Global Clinical trial landscape- Focus on Asia Pacific Asia contributed close to 24,000 melanoma cases in 2020, with Australia and New Zealand having the highest incidence rates in the world. Download July 13, 2022 Report Multiple myeloma - Asia pacific – clinical Trial landscape Multiple myeloma cases are increasing in Asia, with the region currently contributing to more than 35% of the projected global incidence, with China, India, and Japan comprising more than a quarter Download September 1, 2023 Report Nasopharyngeal Carcinoma: Global Clinical Trial Landscape Nasopharyngeal carcinoma is the most common cancer originating from the nasopharyngeal epithelium and is often undifferentiated. It is mainly found in Asia and Africa. Download December 17, 2021 Report Gastric cancer Clinical trial landscape Asia-pacific Nearly 75% of the new gastric cancer cases in the world are concentrated in Asia, with China showing the highest incidence and mortality. Download April 5, 2023 Report Prostate Cancer Global Clinical trial landscape - Focus on Asia Pacific In 2020, Asia accounted for more than a quarter of worldwide Prostate cancer incidence cases, with China and Japan together contributing over 220,000 new cases in the region. Download May 24, 2022 Report Renal Cell Carcinoma Owing to its large population base, Asia accounts for over 35% of the estimated global incidence of Renal cell carcinoma, with China, Japan, and India collectively contributing to over a quarter of Download June 2, 2023 Whitepaper Oncolytic Virus Therapies– Global Clinical Trial Landscape - Focus On Asia Pacific Asia Pacific showed consistent and the fastest growth in Oncolytic Virus therapy trials in the past five years, excee Download November 29, 2021 Report Colorectal cancer clinical trials landscape asia pacific The incidence of colorectal cancer cases is rapidly growing in Asia-Pacific and the region now accounts for more than half of all new cases diagnosed globally. Download March 3, 2023 Report Acute Myeloid Leukemia (AML) - Global Clinical Trial Landscape-Focus on Asia Pacific Asia Pacific accounted for approximately 46,000 AML cases in 2020, with China, India, and Japan accounting for 40% of the global cases. Download February 24, 2022 Report Small cell lung cancer Each year, there are over 300,000 new cases of Small Cell Lung Cancer globally, with Asia accounting for nearly 60% of the cases. Download June 2-6, 2023 Events ASCO Annual Meeting (In Person)Chicago Read More October 12, 2021 Report Clinical trial landscape of Liver cancer in asia pacific According to the Globocan 2020 report, liver cancer is the fourth most frequent cancer in Asia, with the region accounting for over 70% of all new liver cancer cases worldwide. Download September 29, 2022 Report Bile duct cancer (Cholangiocarcinoma) Asia Pacific – Clinical Trial Landscape Asia has a significantly greater prevalence of Cholangiocarcinoma, in comparison to the other parts of the world, with China, South Korea, Thailand, and Taiwan having the highest incidence rates in Download January 21, 2022 Report Thyroid cancer Asia accounted for almost 60% of the global incidence, mortality and five-year prevalence in 2020, with the highest incidence rates found in Australia and Eastern Asia for both sexes. Download April 28, 2023 Report Ovarian Cancer - Global Clinical trial landscape- Focus on Asia Pacific Asia accounted for more than half of the global Ovarian Cancer incidence cases in 2020, with majority of them contributed by China and India. Download July 27, 2022 Report Solid tumors - Asia Pacific – Clinical trial Landscape There were over 8.2 million new cases and over 5 million deaths due to solid cancers in Asia, with the region accounting for half of the new cancer cases and 60% of the world’s deaths in 2020. Download August 28, 2023 Report Gallbladder Cancer: Global Clinical Trial Landscape Gallbladder cancer develops when malignant cells proliferate in the mucosal layer of the gallbladder and expand outward. Download January 8, 2016 News Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals Read more August 31, 2009 News NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION Read more New Zealand Importantly, New Zealand also offer alternative recruitment potential to northern hemisphere seas Clinical Research Associate (CRA) Essentials Program JANUARY 2022 INTAKE – AUSTRALIA AND NEW ZEALAND We are internationally recognized as a leading regional ful Philippines The Philippines is the world’s 12th most populous country, with a growing, newly industrialized e May 31, 2013 News Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in… Imugene’s clinical review for HER-Vaxx is now complete HER-Vaxx Phase 1b/2 in gast Read more Associate Project Manager Program JANUARY 2022 INTAKE – AUSTRALIA April 24, 2020 News Biotechnology Companies Turning to Asia-Pacific for Clinical Trials During North America Slowdown. Biotechnology sponsors are attracted to the region because sites ha Read more Expertise Clinical and Regulatory Strategy Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and Proposals, Budgets and Contracts Graduate Program January 2023 Intake - Malaysia South Korea South Korea has a population of 51 million, offers world-class infrastructure and is fast becomin June 15, 2011 News SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations… SureClinical eTMF Cloud Selected by Novotech to automate an Read more January 13, 2020 News Asia-Pacific has record year for clinical trials according to Novotech San Francisco, CA – Novotech the largest biotech CRO in the Asia-Pacific said th Read more July 5, 2011 News NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL Sydney, November 24, 2015 - US-Australian drug discovery company, Novogen Limited (ASX:NRT: NASDA Read more November 9, 2021 News Novotech Platinum Sponsor at ChinaTrials13 Summit Shanghai 2021 Sydney - Novotech, a leading biotech specialist CRO in the Asia-Pacific region, Read more January 29, 2019 News Novotech Update: South Korea to cover standard of care for patients participating in clinical trials In a recent update, South Korea’s National Health Insurance Program outlined plans to also cover Read more October 25, 2022 Whitepaper The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval Global biopharma companies are looking to capitalize on value creation across different geographic regions through ut Download August 28, 2023 FAQ Advancing Treatment of Gallbladder Cancer (GBC): Clinical Trials, New Drugs, and Innovative Strategies GBC presents unique challenges due to its often-advanced stage at diagnosis. Read More September 13, 2023 FAQ Unlocking the Future of Healthcare: Exploring Global Clinical Trends in Cell & Gene Therapy Cell and gene therapy (CGT) is one of the most advanced areas of medicine that can effectively transform our own bodies into disease-fighting agents. Read More July 14, 2022 News Novotech’s APAC and USA Leadership Teams at BIO 2022 San Diego - USA - Novotech, the leading Asia Pacific biotech specialist CRO whic Read more October 27, 2022 FAQ Contract Research Organisations: Market and Trends The Contract Research Organisation (CRO) industry is constantly changing and growing due to various key factors like a growing healthcare sector, research funds, a growing patient population worldw Read More June 15, 2020 News Novotech Partners with South Korea’s 1,300-bed Pusan National University Hospital The leading Asia-Pacific biotech Read more July 29, 2020 FAQ How CRO Companies Work? - A Basic Overview It’s quite common for pharmaceutical and biotechnology companies introducing new drugs and treatment to outsource trials of new medication or procedures to CRO Companies. Read More June 30, 2022 News Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022 Seoul, South Korea - Novotech, the leading Asia Pacific biotech specialist CRO w Read more May 26, 2022 News Novotech Acquires US CRO - Expands Global Expertise Singapore and Charleston, SC - Novotech, the leading Asia-Pacific Read more September 13, 2023 Whitepaper Cell and Gene Therapies Global Clinical Trial Landscape (2018-2022) With the potential to completely transform how we treat life-threatening diseases, cell and gene therapies are at the Download May 10, 2014 News Novotech announces four country Asia expansion at AusBiotech 2009 October 27, 2009 Read more Solution Site Management Organization (SMO) July 21, 2022 Webinar Evolution of cell & gene therapy in China: the case for universal CAR-T Arsalan: Hi, everyone, Arsalan Arif here with Endpoints News, and thanks for joining us to Watch December 10, 2019 News Novotech CRO sees changing landscape in Hemato-Oncology at ASH 2019 Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orla Read more Europe Europe is an attractive clinical development region due to the commercial size o April 9, 2020 News Novotech selected for new COVID-19 Clinical Trial in Asia-Pacific Novotech has been engag Read more August 12, 2020 Webinar Running First-in-human and Vaccines Studies in Australia Arsalan Arif: Hi everyone and welcome to our webinar. Watch November 22, 2019 News Novotech’s Clinical Network Services wins GENE Awards for Industry excellence in biotech drug… Clinical Network Services, a subsidiary of Novotech, the Asia-Pacific CRO, was awarded a prestigi Read more July 25, 2022 News Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award… Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has b Read more October 21, 2021 Webinar Driving efficiencies through virtual trial solutions in Asia Pacific Arsalan Arif: Hi everyone. Watch June 22, 2022 News Novotech Receives CRO Leadership Award for Exceeding Customer Expectations Chicago - USA - Novotech, the leading Asia Pacific biotech specialist CRO which Read more September 24, 2021 News Regional Lead CRA THE NEXT STEP IN YOUR CLINICAL RESEARCH CAREER If you have passion for the clinical ope Read more Load More
